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Results and Conclusions 
• MB-MDR can be successfully used on the genome-wide scale in eQTL studies for trans-epistasis assessement 
• Trans-epistasis effect expressed as a ratio is able to characterize genome-wide impacts of cisSNPs 
• The maximum trans-epistasis effect was 0.056 (compared to a mean of 0.00116 in “null data”) 
• More than 95% (1763/1844) of the significant cisSNPs in our data  were significantly modified by transSNPs 
• The distribution of trans-epistasis values significantly deviated from normality (Fig.2-A) 
• Low association was found between Fig.1-Step 1 (GLS based) and  Fig.1-Step 4 (based on trans-epistasis effects) rankings of 
significant cisSNPs (Pearson r2= 0.00046) 
• Annotation to KEGG pathways of genes associated with doubly selected eQTLs (GLS and MB-MDR) suggest that asthma CAMP cohort 
patients may have aberrations associated to vascular smooth muscle contraction,  intra-celular signaling and protein  degradation 
pathways (Fig.3)  
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Methods 
Our CAMP based dataset [1] consisted of 153 caucassian non-
smoker subjects with ages ranging between 16-25. Each 
selected subject was represented by 19,451 gene expression 
values and 507,945 SNPs. Preliminary eQTL analysis was done 
within GLS regression framework. The FDR was controlled at 
0.05, generating a final list of 1844 significant cisSNPs. 
Data preparation for MB-MDR interaction analysis 
Genotype and expression sample IDs were matched. The gene 
coding regions were identified using  GenomicFeatures library 
in R. Two Mb (2x106 bp) windows in either direction were 
added delimiting the effective range for cisSNPs on gene 
expression. The SNPs outside this range where defined as 
transSNPs. For MB-MDR runs the gene expression values  for  
each eQTL were rank transformed to normality using  
GenABEL library functions in R and analyzed consecutively 
using default options in quantitative trait MB-MDR analysis. 
MB-MDR was modified to work under multi-trait context 
(trait = gene expression value). The assessment of significant 
cis/transSNP interactions was based on marginal 
permutation-derived null distributions (999 data replicates). 
All cis/transSNP pairs with a p-value  p≤0.001 (not corrected 
for multiple-testing) where retained for further analysis 
Determination of trans-epistasis threshold 
The “trans-epistasis effect” on a particular cisSNP was defined 
as the ratio of significant modifier effects to the cisSNP under 
consideration (cis/transSNP pairs  with MB-MDR marginal 
p≤0.001) out of a total number of 507,945 possible pairings 
with the cisSNP. We randomly sampled on average 200 MB-
MDR marginal p-values, for each of 1844 eQTLs, and repeated 
this process 100 times. For each replicate we then computed 
the 1844 trans-epistasis effects. The distribution of trans-
epistasis effects appeared to be consistent across replicates. 
The null distribution of the 1st replicate is shown in Fig . 2B. 
From these distributions we derived a critical value for the 
trans-espistasis effect. It was fixed at 0.00124±2.4x10-8 using 
α significance level of 0.05 and one-sided alternative 
hypothesis. A total of 1,763 out of 1,844 cisSNPs remained  
after  this  trans-epistasis effect filtering. 
KEGG pathway enrichment and annotation 
The KEGG pathway database, containing gene mappings to 
186 known biological pathways, was used to annotate the 
genes corresponding to the 1,763 eQTLs obtained from the 
previous step. Notably, some genes did not map to any 
pathway  or were mapped  to multiple pathways (Fig.3). 
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Introduction 
Epistasis is likely to underlie most complex traits, including 
gene expression, yet it is very difficult to detect using 
standard approaches. SNPs located inside a gene coding 
region or in its vicinity (i.e. ≤2 Mb from each 5’ and 3’ side) 
can influence the corresponding gene expression levels. 
These expression quantitative trait loci (eQTLs) are referred 
to as cisSNPs.  In contrast, eQTLs that are outside the 
aforementioned gene range can also influence the gene’s 
expression, in which case, they are called transSNPS to that 
gene. In this study we considered significant cisSNPs  
previously identified via generalized least squares (GLS) 
regression modeling. We then identified those genes 
transcripts whose expression is regulated by cis/transSNP 
interaction. In this work we aimed at identifying transcripts 
whose expression is regulated by a cis/transSNP interactions 
using Model-Based Multifactor Dimensionality Reduction 
(MB-MDR) [2]. This model-free approach to detect trans-
epistasis involves reducing a high-dimensional GxG space to 
GxG factor levels that either exhibit high evidence, low 
evidence or no evidence at all for their association to gene 
expression levels of interest.  
Our protocol was applied on real-life data from the childhood 
asthma management program (CAMP) [1]. It involved 
coupling a traditional a priori eQTL search to an a posteriori 
trans-epistasis analysis to identify genetic modifiers to 
statistically significant cisSNPs. Such an approach allows to 
reveal previously unreported inter-dependencies that may be 
important in understanding of biological mechanisms 
underlying human complex diseases such as asthma.   
The proposed protocol identified a large number trans-
epistasis gene-gene effects of eQTLs.  
Fig 2: Q-Q plots assessing 1844 trans-epistasis effects based on A) CAMP and B) randomly permuted data against  normal distribution. The  
blue line passes through  1st and 3rd quartiles (0.25,0.75). They y-axis refers to trans-epistasis effect with theoretical 0 to 1 range 
Fig 1: Outline of trans-epistatis eQTL analysis method. Step 1: Identify significant eQTLs via GLS; Step 2: Identify transSNPs interacting with 
significant cisSNPs from step 1. Step 3: Filter cis/trans SNP pairs with MB-MDR marginal p≤ 0.001; Step 4: filter  eQTLs with trans-epistasis 
effect > 0.00124 (based on 100 random samples) and annotate  eQTLs corresponding genes to KEGG pathways   
Fig 3: KEGG pathways enrichment based on the list of genes  linked to eQTLs with significant trans-epistasis effect (1763 genes). The top 15 
KEGG pathways  with  the  highest number of occurrences within this list are shown. Asthma-related  pathways are  indicated in red. 
